ANN ARBOR — ArborMetrix Inc., a provider of real-time health care analytics, has increased its series b financing by $1.3 million to allow Renaissance Venture Capital Fund and Detroit Innovate to invest in their company, accelerating ArborMetrix’s national market expansion to meet surging demand for its clinical performance analytics tools.
Their analytics enable healthcare providers and payers to improve the quality, safety, and cost-effectiveness of surgical and other specialty care. The earlier round of series b financing, announced in July, was led by RPM Ventures alongside existing investors Arboretum Ventures and Wolverine Venture Fund.
The Renaissance Venture Capital Fund supports the growth of venture capital in Michigan while serving as a bridge between the state’s emerging innovation company community and its industrial and commercial base.
Detroit Innovate is a southeast Michigan-focused early stage investment fund targeting technologies in the health care, transportation, advanced manufacturing, and resource efficiency sectors.